Cargando…
Agent-based computational modeling of glioblastoma predicts that stromal density is central to oncolytic virus efficacy
Oncolytic viruses (OVs) are emerging cancer immunotherapy. Despite notable successes in the treatment of some tumors, OV therapy for central nervous system cancers has failed to show efficacy. We used an ex vivo tumor model developed from human glioblastoma tissue to evaluate the infiltration of her...
Autores principales: | Jenner, Adrianne L., Smalley, Munisha, Goldman, David, Goins, William F., Cobbs, Charles S., Puchalski, Ralph B., Chiocca, E. Antonio, Lawler, Sean, Macklin, Paul, Goldman, Aaron, Craig, Morgan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9142563/ https://www.ncbi.nlm.nih.gov/pubmed/35637733 http://dx.doi.org/10.1016/j.isci.2022.104395 |
Ejemplares similares
-
Cancer Immunotherapy and Personalized Medicine: Emerging Technologies and Biomarker-Based Approaches
por: Maciejko, Laura, et al.
Publicado: (2017) -
Systems biology informed neural networks (SBINN) predict response and novel combinations for PD-1 checkpoint blockade
por: Przedborski, Michelle, et al.
Publicado: (2021) -
HSV-1 Oncolytic Viruses from Bench to Bedside: An Overview of Current Clinical Trials
por: Koch, Marilin S., et al.
Publicado: (2020) -
In silico trials predict that combination strategies for enhancing vesicular stomatitis oncolytic virus are determined by tumor aggressivity
por: Jenner, Adrianne L, et al.
Publicado: (2021) -
Systemic high-dose dexamethasone treatment may modulate the efficacy of intratumoral viral oncolytic immunotherapy in glioblastoma models
por: Koch, Marilin S, et al.
Publicado: (2022)